CAS 2014384-91-7 Nangibotide

Send Inquiry
CAS 2014384-91-7 Nangibotide
Details
CAS: 2014384-91-7
Core structure: Synthetic dodecapeptide TREM-1 receptor antagonist, sequence derived from the binding domain of TREM-1 ligand, competitively blocks the activation of triggering receptor expressed on myeloid cells-1, inhibits excessive inflammatory cascade, for sepsis and severe inflammation research
We also provide specifications from crude to 99% purity, please contact us for details!

Related documents

COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Immunomodulatory Peptide / Anti-inflammatory Receptor Antagonist Peptide
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 2014384-91-7 nangibotide in China, also supports custom service. Welcome to wholesale bulk high quality cas 2014384-91-7 nangibotide from our factory. Contact us for more details.

 

Product name CAS:2014384‑91‑7:Nangibotide
Description Nangibotide (also known as LR12) is a specific antagonist peptide targeting triggering receptor expressed on myeloid cells 1 (TREM‑1). It competitively binds to TREM‑1 receptors, blocks endogenous ligand‑mediated receptor activation and downstream inflammatory signaling pathways, inhibits pro‑inflammatory cytokine storm and excessive myeloid cell activation, while not affecting the normal antibacterial immune defense of the body. It can significantly reduce excessive inflammatory injury and improve survival rate in models of sepsis, septic shock and severe inflammation. It is a cutting‑edge tool peptide for the study of severe inflammation and immune disorder mechanisms.
Peptide purity (HPLC, %) 95%/98%/99%
Theoretical molecular weight (Da) ~1400 (subject to actual synthetic batch)
Structure type Linear dodecapeptide, native amino acid sequence

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Modification Type Length (aa)
Nangibotide Nangibotide; LR12 TREM-1 antagonism, Cytokine storm inhibition, Sepsis research, Immunomodulation, Severe anti-inflammation, Peptide drug TREM-1 ligand homologous dodecapeptide with receptor binding core sequence Large linear peptide, subject to actual batch MS - ~1400 (theoretical) Native unmodified 12

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-NAN001 white powder Store at -20℃, sealed, dry & protected from light, aliquoted; avoid repeated freeze-thaw cycles and contamination Stable for 2 weeks at 2-8℃ sealed & dry; ice pack shipping recommended Stable for 72h at 4℃ under sterile conditions; prone to degradation and inactivation by serum proteases at room temperature**Good water solubility, freely soluble in neutral physiological buffer**. Linear short peptide easily degraded by proteases Stable for 2 years at -20℃ under dry & dark conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-NAN001 TREM-1 receptor specific antagonist peptide that blocks excessive inflammatory cascade and alleviates severe inflammatory injury such as sepsis Nangibotide competitively occupies TREM-1 receptors on myeloid cell surface by mimicking the binding sequence of endogenous ligands, blocks ligand-induced receptor dimerization and activation of downstream SYK and NF-κB inflammatory signaling pathways, inhibits the massive release of pro-inflammatory cytokines such as TNF-α, IL-1β and IL-6, and alleviates cytokine storm and tissue organ damage. Different from broad-spectrum anti-inflammatory drugs, it only targets the TREM-1-mediated excessive inflammatory pathway, does not inhibit the normal pathogen-clearing immune function of the body, with lower infection risk. It is a novel targeted tool for the study of severe infection, sterile inflammation and other diseases. Sepsis and septic shock, Severe inflammation research, Cytokine storm mechanism, Myeloid cell immunity, Acute organ injury, Anti-inflammatory peptide development Triggering Receptor Expressed on Myeloid cells 1 (TREM-1); SYK/NF-κB inflammatory signaling pathway; Cytokine storm inhibitory pathway

Hot Tags: cas 2014384-91-7 nangibotide, China cas 2014384-91-7 nangibotide manufacturers, suppliers, factory, 129954-34-3, 137525-51-0, CAS 1415456 99 3, CAS 1566590 77 9, Melanotan I acetate, Retatrutide

Send Inquiry